QA: VIVUS INC in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000881524_2020_VIVUS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Liabilities', 'missing_ratio': 0.0020927690145244415, 'aggregate_val': 287532000, 'exp_sum': 288135000, 'exp_to_value': {'LiabilitiesCurrent': 225146000, 'LiabilitiesNoncurrent': 61784000, 'remainder_Liabilities': 1205000}}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.001806102339702702, 'aggregate_val': 218308000, 'exp_sum': 218703000, 'exp_to_value': {'AssetsCurrent': 96800000, 'IntangibleAssetsNetIncludingGoodwill': 0, 'PropertyPlantAndEquipmentNet': 233000, 'remainder_Assets': 121670000}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000881524')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000881524, VIVUS INC

  xvar xval
0 AssetsCurrent 96,800,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 233,000
3 remainder_Assets 121,275,000
4 LiabilitiesCurrent 225,146,000
5 LiabilitiesNoncurrent 61,784,000
6 remainder_Liabilities 602,000
7 CostOfGoodsAndServicesSold 15,671,000
8 SellingGeneralAndAdministrativeExpense 22,071,000
9 ResearchAndDevelopmentExpense 10,467,000
10 remainder_Expenses 32,541,000
11 remainder_Revenues 69,760,000
12 remainder_NetIncome -20,513,000
13 remainder_ComprehensiveNetIncome 235,000
  yvar yval
0 Assets 218,308,000
1 Liabilities 287,532,000
2 Expenses 80,750,000
3 Revenues 69,760,000
4 StockholdersEquity -69,224,000
5 NetIncome -31,503,000
6 ComprehensiveNetIncome -31,385,500
7 BaseVar 338,549,000
8 EconomicCapitalRatio -0.595

Edgar->Model Mapping

Feature Distribution

Change over Time